Browse > Article
http://dx.doi.org/10.15432/JKTO.2016.21.2.051

A review of herbal medicines for chemotherapy induced peripheral neuropathy  

Park, Bongki (Department of Internal Korean Medicine, Ilsan Oriental Hospital, Dongguk University medical center)
Publication Information
Journal of Korean Traditional Oncology / v.21, no.2, 2016 , pp. 51-61 More about this Journal
Abstract
Background : Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect in cancer patients who were exposed to chemotherapy. CIPN impacts on the quality of life and could delay chemotherapy. The aim of this review was to assess the therapeutic effectiveness of herbal medicine in CIPN patients. Methods : Randomized controlled trials (RCTs) were included in this review. We searched MEDLINE, Cochrane database, EMBASE, CNKI, Wanfang and four Korean databases without restrictions on time or language. The risk of bias was assessed using the Cochrane risk of bias tool. Results : Eleven RCTs involving 706 patients met the inclusion criteria. Eleven different herbal medicines were examined in the included trials. Almost RCTs showed insufficiency in the reporting randomization method and allocation concealment. One trial used allocation concealment and a double-blinding method. Five studies reported that participants dropped out of RCTs and conducted an 'as-treated analysis'. One trials reported adverse effects of herbal medicine. In ten of the eleven trials, the use of herbal medicine had shown significant differences in clinical symptoms or nerve conduction velocity. Conclusions : The use of herbal medicines for CIPN showed significant improvements in the management of CIPN. However, conclusions cannot be drawn because of the generally low quality of methodology and low quantity of data for each single herbal medicine. Further rigorous trials are needed.
Keywords
Cancer; Peripheral Nerve Injuries; herbal medicine; traditional East Asian medicine; randomized clinical trials; review;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Argyriou AA, Bruna J, Marmiroli P, Cavaletti G. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol. 82: 51-77, 2012.   DOI
2 Gewandter JS, Fan L, Magnuson A, Mustian K, Peppone L, Heckler C, et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 21: 2059-2066, 2013.   DOI
3 Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. Journal of the peripheral nervous system : JPNS. 13: 27-46, 2008.   DOI
4 Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, et al. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA: a cancer journal for clinicians. 63: 419-437, 2013.   DOI
5 Chu SH, Lee YJ, Lee ES, Geng Y, Wang XS, Cleeland CS. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 23: 513-524, 2015.   DOI
6 Park C, Lim L, Lim Y, Hong K. Consideration of the Son-Bal Jeorim in oriental and western medicine. Institute of Korean medicine research of Daejoen University. 13: 47-59, 2004.
7 Lou Y, Tian A, Zhang X, Feng L, Tan H, Zhu S, et al. Randomized, multi-center, double-blinded, controlled clinical trial of external treatment of TCM on peripheral neuropathy caused by chemotherapy. China Journal of Traditional Chinese Medicine and Pharmacy. 29: 2682-2685, 2014.
8 Shen J, He S, Sun X, Hu N, Cai Y. Clinical Study on External Bath of Modified Huangqi Guizhi Wuwu Decoction for Peripheral Neurotoxicity Induced by Oxaliplatin. Chinese Journal of Information on Traditional Chinese Medicine. 22: 13-15, 2015.
9 Ke Y, Mo M, Chen C, Hu Z. Experience on external bath for chemotherapy-induced peripheral neuropathy in multiple myeloma Journal of Shaanxi University of Chinese Medicine. 2016.
10 Cheng XL, Liu HQ, Wang Q, Huo JG, Wang XN, Cao P. Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective. Front Pharmacol. 6: 234, 2015.
11 Franconi G, Manni L, Schroder S, Marchetti P, Robinson N. A systematic review of experimental and clinical acupuncture in chemotherapy-induced peripheral neuropathy. Evidence-based complementary and alternative medicine : eCAM. 2013: 516916, 2013.
12 Deng B, Jia L, Cheng Z. Radix Astragali-Based Chinese Herbal Medicine for Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM. 2016: 2421876, 2016.
13 Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherapy-induced peripheral neuropathy: Current status and progress. Gynecologic oncology. 140: 176-183, 2016.   DOI
14 Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. Journal of neurology. 249: 9-17, 2002.   DOI
15 Lee G, Kim SK. Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy. Molecules. 21: E1252, 2016.   DOI
16 Zhang X. The Observation of Therapeutic Effects of Baweiyangmaitang on the Treatment of Chemotherapy-Induced Peripheral Neuropathy: Heilongjiang University of Chinese medicine; 2011.
17 Higgins AD, Sterne JAC. Assessing risk of bias in included studies. 2011. Available from: http://www.cochrane-handbook.org
18 Jia L, Lou Y. The external use of Chinese herbs in chemotherapy-induced peripheral neuropathy : A Clinical Study. The 16th annual meeting of china association for science and technology 2009. p. 110-113.
19 Han F. A clinical research of the external use of Wenjing Huoxue Tonglou formula in chemotherapy induced peripheral neurotoxicity: Guangzhou University of Chinese medicine; 2011.
20 Chen C, Liu Q. Observation of therapeutic effects of vitamin B12 combined with traditional Chinese medicine for chemotherapy induced peripheral neuropathy. Medical Frontier. 129-130, 2012.
21 Jia L, Lou Y, Liu M, Wan D, Zhu S, Tan H. Randomized, multicenter, phase II trial of compound Chinese herbal extract LC07 versus placebo for external treatment of chemotherapy-induced peripheral neuropathy. Annals of Oncology. 23: ix29, 2012.   DOI
22 Kaku H, Kumagai S, Onoue H, Takada A, Shoji T, Miura F, et al. Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study. Experimental and Therapeutic Medicine. 3: 60-65, 2012.   DOI
23 Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 22: 2261-2269, 2014.   DOI
24 Zhou H. Observation of therapeutic effects of the nebulization of Chinese herbs in oxaliplatin-induced peripheral neuropathy. Modern Diagnosis and Treatment. 2013.
25 Wei M. Cinical research of the therapeutic effects on the external use of wenyangtongbi method for chemotherapy-induced peripheral neuropathy: Beijing University of Chinese medicine; 2014.
26 Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. Jama. 309: 1359-1367, 2013.   DOI
27 Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-oncology. 14 Suppl 4: iv45-54, 2012.
28 Pachman DR, Watson JC, Lustberg MB, Wagner-Johnston ND, Chan A, Broadfield L, et al. Management options for established chemotherapy-induced peripheral neuropathy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 22: 2281-2295, 2014.   DOI